Enhancing quality and impact of early phase dose-finding clinical trial protocols: SPIRIT Dose-finding Extension (SPIRIT-DEFINE) guidance. (2023)
Attributed to:
MICA: BIOlogical Factors that Limit sustAined Remission in rhEumatoid arthritis (the BIO-FLARE study)
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1136/bmj-2023-076386
PubMed Identifier: 37863491
Publication URI: http://europepmc.org/abstract/MED/37863491
Type: Journal Article/Review
Volume: 383
Parent Publication: BMJ (Clinical research ed.)
ISSN: 0959-8138